Tags : Monoclonal Antibodies

Biotech COVID-19

AstraZeneca Focuses on the Discovery of Monoclonal Antibodies Neutralizing SARS-CoV-2

Shots: AstraZeneca highlighted its efforts towards the development of Ab against the pandemic SARS-CoV-2 virus by deploying its internal expertise and via news collaboration with government and academia The Chinese Academy of Sciences and Vanderbilt University Medical Center are providing AstraZeneca with genetic sequences for Ab, discovered against SARS2-CoV-2 for further in silico and in […]Read More